Molecular and cell biologist Linda Geng is one of 13 recipients nationwide of the Center's 2012 Harold M. Weintraub Graduate Student Award
March 12, 2012
Dr. Linda Geng, formerly of the Fred Hutchinson Cancer Research Center's Tapscott Lab, is among 13 graduate students from institutions throughout North America chosen to receive the Center's 2012 Harold M. Weintraub Graduate Student Award.
Discoveries may result in biomarker test for facioscapulohumeral muscular dystrophy, a disease that initially affects the skeletal muscles of the face, scapula and upper arms
Jan. 30, 2012
| By Dean Forbes
Continuing a series of groundbreaking discoveries begun in 2010 about the genetic causes of the third most common form of inherited muscular dystrophy, an international team of researchers led by the Hutchinson Center's Dr. Stephen Tapscott has identified the genes and proteins that damage muscle cells, as well as the mechanisms that can cause the disease.
Tapscott’s global team discovers expression of an MD-causing gene thought to be inactive in humans; work may lead to new therapy targets, evolutionary insights
Nov. 1, 2010
| By Kristen Woodward
An international team of researchers led by the Fred Hutchinson Cancer Research Center’s Dr. Stephen Tapscott has made a second critical advance in determining the cause of a common form of muscular dystrophy known as facioscapulohumeral dystrophy, or FSHD.
Fred Hutch is proud to be an Equal Opportunity and VEVRAA Employer. We are committed to cultivating a workplace in which diverse perspectives and experiences are welcomed and respected. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability, marital or veteran status, sexual orientation, gender identity, political ideology, or membership in any other legally protected class. We are an Affirmative Action employer. We encourage individuals with diverse backgrounds to apply and desire priority referrals of protected veterans. Read the EEO is the Law poster here.